Why is Caplin Point Lab falling/rising?

As of 05-Aug, Caplin Point Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 1,960.40, which reflects a decrease of Rs 47.85 or 2.38%. Today's price summary indicates that the stock has underperformed its sector by 1.43%, with an intraday low of Rs 1,950.05, marking a drop of 2.9%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Additionally, there has been a significant decline in investor participation, with delivery volume falling by 54.35% compared to the 5-day average. Over the past week, the stock has decreased by 6.20%, while it has also shown a year-to-date decline of 21.64%, contrasting with a positive return of 26.94% over the past year.
In the broader market context, the Sensex has only decreased by 0.77% over the past week, indicating that Caplin Point Laboratories Ltd's short-term performance is lagging behind the benchmark. Despite the recent downturn, the company has demonstrated strong fundamentals, including high management efficiency with a return on equity of 19.84%, a low debt-to-equity ratio, and consistent positive results over the last 11 quarters. Furthermore, institutional investors have increased their stake, which may provide some support for the stock. However, the recent decline in stock price and trading volume suggests that market sentiment is currently negative, overshadowing the company's solid financial performance.